Product
Flu D-QIV
1 clinical trial
1 indication
Indication
Herpes ZosterClinical trial
A Phase III, Randomized, Open-label, Controlled, Multicenter Study to Evaluate the Immune Response and Safety of Both Herpes Zoster Subunit Vaccine in Healthy Adults Aged 50 Years and Older AND the Influenza Virus Vaccine in Healthy Adults Aged 18 Years and Older When Administered Sequentially or Coadministered With mRNA-1273 Booster VaccinationStatus: Completed, Estimated PCD: 2022-08-29